Hang Sheng Zhou
Amministratore Delegato presso Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd.
Profilo
Hang Sheng Zhou is currently the Chief Executive Officer at Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd.
Prior to this, he worked as the Chief Financial Officer & Managing Director at Humanwell Healthcare (Group) Co., Ltd.
Dr. Zhou also served as an Independent Non-Executive Director at AbelZeta Pharma, Inc. from 2016 to 2021.
He received his undergraduate degree from Wuhan University and his doctorate from Beijing Institute of Technology.
Posizioni attive di Hang Sheng Zhou
| Società | Posizione | Inizio |
|---|---|---|
Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd.
 Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. Financial ConglomeratesFinance Part of Wuhan Dangdai Technology Industry Group Co. Ltd., Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. operates as an investment holding company. The company is based in Wuhan, China. The CEO of the Chinese company is Hang Sheng Zhou. | Amministratore Delegato | - |
Precedenti posizioni note di Hang Sheng Zhou
| Società | Posizione | Fine |
|---|---|---|
| CELLULAR BIOMEDICINE GROUP, INC. | Direttore/Membro del Consiglio | 19/02/2021 |
| HUMANWELL HEALTHCARE (GROUP) CO.,LTD. | Amministratore Delegato | - |
Formazione di Hang Sheng Zhou
| Beijing Institute of Technology | Doctorate Degree |
| Wuhan University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HUMANWELL HEALTHCARE (GROUP) CO.,LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
AbelZeta Pharma, Inc.
 AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD. | Health Technology |
Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd.
Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. Financial ConglomeratesFinance Part of Wuhan Dangdai Technology Industry Group Co. Ltd., Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. operates as an investment holding company. The company is based in Wuhan, China. The CEO of the Chinese company is Hang Sheng Zhou. | Finance |
- Borsa valori
- Insiders
- Hang Sheng Zhou
